Search

everythinglearnresearchcommunity

for

Search:↓

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Urinary PSA could be an early marker for enlarged prostate.

Adherence to finasteride treatment for prostate issues is generally low.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Hair loss linked to prostate enlargement; stress and family history important factors.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Gene variation affects prostate issues and hair loss.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

BPH treatments are improving with personalized medicine and better surgical options.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.